All Posts By

GenomeScan

Report on the Translational Research Network for Prostate Cancer (TransPot)

By | Blog | No Comments

Hi everybody! I’m Mario Cangiano, an Early stage researcher (ESR) within the EU funded project TransPot (the Translational Research Network for Prostate Cancer), working at the R&D department of GenomeScan. Transpot is a multi-center research program designed to tackle aggressive prostate cancer (PCa) and to train 11 ESR in the field of systems biology, namely the holistic representation of biological…

Read More

Competitive, fast, and adaptable RNA Sequencing services

By | News | No Comments

RNA sequencing is an affordable and dependable tool driving R&D and clinical projects. To answer scientific challenges, GenomeScan develops innovative methods to analyze RNA samples. Minute populations of sorted cells or FFPE samples are no longer hampering progression of your project. Get direct access to a wide range of RNA-seq services under ISO/IEC 17015 accreditation. Our experienced scientific team can…

Read More

Widespread RNA circularization events define clinically distinct tumor subtypes

By | Science article | No Comments

This article describes the results of a multidisciplinary prostate cancer study. Prof. dr. ir. Guido Jenster and his collaborators (NGS ProToCol consortium) showed that clinical roles of circular RNA’s are different from their linear counterparts, promoting cell proliferation in localized prostate cancer. GenomeScan contributed to the RNA sequencing and data processing. Read full article: https://www.sciencedirect.com/science/article/pii/S0092867419300583

Read More

How to generate high-quality, alignable sequence data?

By | News | No Comments

Innovation Alert: Mid-read sequencing Sequencing of PE250 reads on the NovaSeq 6000   Printing a book of more than 2 billion pages, every two days. Illumina’s NovaSeq 6000 has made it possible to produce >6 Terabases of high-quality bases per sequencing run. This huge amount keeps the cost per base low and has allowed for the development of many new…

Read More

GenomeScan to offer two Bioinformatics PhD traineeships as part of the EU Horizon 2020 program

By | News | No Comments

Two EU-funded Consortium Grants for PhD training at GenomeScan GenomeScan has been granted two Marie Skłodowska-Curie Actions within the Innovative Training Network calls of the European Union-funded Horizon 2020 Program. These PhD traineeships are part of Horizon 2020 Grants acquired by two different Consortia where Academia and Industry collaborate closely together. Recruitment of PhD candidates with a focus on Bioinformatics…

Read More

Some highlights from SMRT Meeting, Leiden, May 2019

By | Blog | No Comments

Some highlights from SMRT Leiden 2019 Innovation in long-read sequencing applications SMRT Leiden – 7th -9th of May 2019 Arnoud Schmitz – PacBio® expert at GenomeScan The yearly PacBio meeting brings together knowledgeable scientists who share the same enthusiasm for long reads. This two-days event is the perfect place to discuss innovative ideas, visions and meet with inspiring peoples. Here…

Read More

Widespread and Functional RNA Circularizationin Localized Prostate Cancer.

By | Science article | No Comments

Widespread and Functional RNA Circularizationin Localized Prostate Cancer Sujun Chen, Vincent Huang, Xin Xu, Julie Livingstone, Fraser Soares, Jouhyun Jeon, Yong Zeng, Junjie Tony Hua, Jessica Petricca, Haiyang Guo, Miranda Wang, Fouad Yousif, Yuzhe Zhang, Nilgun Donmez, Musaddeque Ahmed, Stas Volik, Anna Lapuk, Melvin L.K. Chua, Lawrence E. Heisler, Adrien Foucal, Natalie S. Fox, Michael Fraser, Vinayak Bhandari, Yu-Jia Shiah,…

Read More

Erasmus MC and LUMC to co-participate in GenomeScan

By | News | 2 Comments

Erasmus MC and Leiden University Medical Center to co-participate in GenomeScan BV and extend their collaboration in the field of molecular diagnostics and R&D   Erasmus MC (Rotterdam, The Netherlands) announced today the acquisition of shares of the fast-growing genomics service provider GenomeScan BV based in Leiden (The Netherlands). Together with the Leiden University Medical Center (LUMC), another shareholder in…

Read More